Dennis Matheis Purchases 14,430 Shares of DarioHealth (NASDAQ:DRIO) Stock

DarioHealth Corp. (NASDAQ:DRIO) Director Dennis Matheis bought 14,430 shares of the firm’s stock in a transaction on Thursday, July 23rd. The shares were bought at an average cost of $6.93 per share, for a total transaction of $99,999.90. Following the purchase, the director owned 43,026 shares of the company’s stock, valued at approximately $298,170.18. The trade was a 50.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

DarioHealth Price Performance

Shares of DRIO opened at $7.10 on Thursday. The company has a quick ratio of 2.62, a current ratio of 3.07 and a debt-to-equity ratio of 0.50. The stock has a market cap of $52.11 million, a PE ratio of -0.80 and a beta of 1.09. DarioHealth Corp. has a 12-month low of $5.84 and a 12-month high of $17.74. The business has a 50-day simple moving average of $7.16 and a two-hundred day simple moving average of $8.60.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of DarioHealth in a report on Friday, July 10th. TD Cowen restated a “hold” rating and set a $11.00 price objective on shares of DarioHealth in a research report on Wednesday, May 13th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $10.00 price target on shares of DarioHealth in a research report on Thursday, May 14th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $10.50.

Hedge Funds Weigh In On DarioHealth

A number of institutional investors and hedge funds have recently modified their holdings of the business. XTX Topco Ltd increased its stake in shares of DarioHealth by 229.0% in the 2nd quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after acquiring an additional 43,513 shares in the last quarter. Geode Capital Management LLC boosted its stake in DarioHealth by 167.9% during the fourth quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after acquiring an additional 31,063 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new stake in DarioHealth in the fourth quarter worth $35,000. 33.39% of the stock is currently owned by institutional investors.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.